LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -127.09%-437.72M | -151.63%-61.23M | -113.76%-97.85M | -684.59%-162.71M | -114.37%-115.93M | -34.38%1.62B | -84.51%118.61M | 25.14%711.14M | -102.31%-20.74M | 248.85%807.04M |
Net income from continuing operations | -168.64%-448.15M | -408.97%-241.51M | -531.18%-76.93M | -197.34%-157.86M | -92.87%28.15M | -73.67%652.89M | -83.93%78.17M | -96.73%17.84M | -79.22%162.18M | -40.83%394.7M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -33.36%6.75M | ---- | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 39.02%148.89M | ---- | ---- | ---- | ---- |
Other non cash items | 16,552.97%565.54M | 173.28%169.94M | 62.58%156.46M | 118.76%163.78M | 17.42%75.36M | -59.61%3.4M | 35.91%-231.89M | -68.25%96.23M | 112.28%74.87M | 101.60%64.18M |
Change In working capital | -184.39%-555.1M | 134.90%10.35M | -129.71%-177.37M | 34.59%-168.63M | -163.03%-219.45M | 246.52%657.8M | -113.62%-29.64M | 312.70%597.06M | -415.39%-257.79M | 174.47%348.16M |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | 220.97%987.39M | ---- | ---- | ---- | ---- |
-Change in inventory | ---- | ---- | ---- | ---- | ---- | -109.46%-13.08M | ---- | ---- | ---- | ---- |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | -1,089.99%-149.73M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | -148.53%-87.93M | ---- | ---- | ---- | ---- |
-Change in other current assets | ---- | ---- | ---- | ---- | ---- | ---900K | ---- | ---- | ---- | ---- |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | -229.00%-77.96M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -127.09%-437.72M | -151.63%-61.23M | -113.76%-97.85M | -684.59%-162.71M | -114.37%-115.93M | -34.38%1.62B | -84.51%118.61M | 25.14%711.14M | -102.31%-20.74M | 248.85%807.04M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -23.62%-1.48B | 211.42%269.26M | 85.62%-65.94M | -557.52%-1.49B | 29.16%-190.48M | -19.79%-1.2B | -241.67M | -458.59M | -226.81M | -257.82%-268.89M |
Net PPE purchase and sale | 67.88%-356.78M | 85.99%-31.22M | 91.63%-33.7M | 46.43%-111.49M | 34.90%-180.37M | 7.85%-1.11B | ---222.86M | ---402.7M | ---208.12M | -173.60%-277.06M |
Net intangibles purchase and sale | 86.01%-10.09M | -100.04%-2K | 99.96%-21K | 100.22%47K | ---10.12M | -59.66%-72.15M | --5.07M | ---55.73M | ---21.49M | --0 |
Net investment purchase and sale | -8,405.09%-1.11B | 1,358.58%300.49M | -20,287.34%-32.21M | -49,452.22%-1.38B | --0 | -105.18%-13.07M | ---23.88M | ---158K | --2.8M | -96.99%8.17M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -23.62%-1.48B | 211.42%269.26M | 85.62%-65.94M | -557.52%-1.49B | 29.16%-190.48M | -19.79%-1.2B | 38.52%-241.67M | 12.65%-458.59M | 9.54%-226.81M | -257.82%-268.89M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -154.03%-795.4M | |||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | -317.95%-522.14M | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | 2,954.77%30.4M | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -119.03%-303.66M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 94.05%-47.36M | 100.59%1.14M | 95.55%-5.54M | 93.12%-36.96M | -110.03%-6M | -154.03%-795.4M | -3,248.78%-193.39M | -22.79%-124.53M | -134.02%-537.34M | --59.87M |
Net cash flow | ||||||||||
Beginning cash position | -13.42%3.05B | -73.99%853.4M | -68.53%997.48M | -34.89%2.69B | -13.42%3.05B | 386.26%3.52B | 7.53%3.28B | -3.49%3.17B | 266.27%4.13B | 386.26%3.52B |
Current changes in cash | -423.18%-1.96B | 166.10%209.17M | -232.26%-169.32M | -115.44%-1.69B | -152.24%-312.42M | -112.78%-375.31M | -186.29%-316.45M | 320.00%128.02M | -135.26%-784.89M | 48.86%598.01M |
Effect of exchange rate changes | 52.57%-46.05M | -128.98%-24.23M | 249.11%25.24M | 99.53%-834K | -479.37%-46.23M | 30.63%-97.08M | -18.44%83.59M | 90.32%-16.93M | -153.03%-175.93M | 495.84%12.19M |
End cash Position | -65.93%1.04B | -65.93%1.04B | -73.99%853.4M | -68.53%997.48M | -34.89%2.69B | -13.42%3.05B | -13.42%3.05B | 7.53%3.28B | -3.49%3.17B | 266.27%4.13B |
Free cash flow | -287.46%-804.59M | 10.36%-92.45M | -152.07%-131.57M | -9.51%-274.15M | -157.82%-306.42M | -64.59%429.2M | 78.73%-103.14M | -55.53%252.71M | -125.07%-250.35M | 307.42%529.98M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |